The GLP1R Agonist Liraglutide Reduces Hyperglucagonemia Induced by the SGLT2 Inhibitor Dapagliflozin via Somatostatin ReleaseChiara Saponaro, Caroline Bonner, François Pattou et al.|Cell Reports|2019Cited by 35